AAPP has curated a collection of essentials that provides resources, references, and clinical pearls for practitioners beginning to practice in psychiatry. Citations of landmark trials are provided. Additional resources are based on questions psychiatric pharmacy specialists frequently receive and aims to provide evidence-based support of recommendations. This also contains references to support monitoring and management of adverse effects and drug interactions of psychotropic medications.
Welcome to the AAPP Foundation!
AAPP members Bethany DiPaula and David Dadiomov represented psychiatric pharmacy on a panel working from June 2022 through September 2024 to form non-legislative recommendations to improve buprenorphine purchase. The study was recently published in Drug and Alcohol Dependence Reports.
On Aug. 11, the Congressional Budget Office (CBO) updated its estimate of the impact of the One Big Beautiful Bill Act, reaffirming that 10 million more people may become uninsured by 2034 (subscription required). The CBO cited the bill’s Medicaid work requirements, which go into effect at the end of 2026, as the primary factor driving coverage losses, leading to approximately 5.3 million individuals losing coverage.